Viewing nowCombinationVifor 10/160 milligrams
Valsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.

MFDS item code 201308433 · Approved 2013.07.29 · Insurance code 642904870
Treatment of essential hypertension not controlled with monotherapy
Patients with essential hypertension can use this medication to manage blood pressure stably when blood pressure is not sufficiently controlled with monotherapy of either amlodipine or valsartan. This medication effectively lowers blood pressure in cases of inadequate response to monotherapy, helping to reduce the risk of complications. Therefore, this medication is used to improve blood pressure control for essential hypertension.
The recommended dose is 1 tablet once daily, taken with water, regardless of meals. It is recommended that the tablet be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not adequately controlled with monotherapy using either individual component, switching directly to this medicine may be considered as follows: ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dosage adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or higher). However, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients 65 years of age or older: Caution should be exercised when increasing the dose.
The safety and efficacy of this medicine have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.
This medication may cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. Patients with an allergy to this medication or those with specific kidney and liver disorders, as well as pregnant or breastfeeding women, should not take this medication. Patients with fluid or sodium depletion may experience hypotension, so it is important to thoroughly check their condition before administration and seek medical observation if necessary. Patients with high potassium levels should exercise caution when taking this medication together with other potassium-increasing drugs and should have their potassium levels monitored frequently. Patients with renal artery stenosis or those who have received a kidney transplant should be administered this medication cautiously due to the risk of worsening renal function. If symptoms of angioedema such as swelling of the face or neck occur during treatment, the medication should be stopped immediately and a physician should be consulted. Patients with heart failure or after myocardial infarction should have their renal function and blood pressure periodically monitored while on this medication, particularly for patients with severe heart failure. This medication lowers blood pressure, and overdose may result in dizziness and severe hypotension, so it is essential to adhere strictly to the prescribed dosage and report any abnormal symptoms to medical personnel. Caution is advised when driving or operating machinery as dizziness or fatigue may occur. Interactions may occur when taking this medication with other antihypertensives, potassium supplements, certain anti-inflammatory drugs (NSAIDs), etc., so it is essential to consult with a physician. It is safer for women who are pregnant or planning to become pregnant to avoid the use of this medication, and breastfeeding women should also be advised against taking it. Children under 18 years of age are not recommended to use this medication as its safety and efficacy have not been adequately established. Elderly patients can take similar doses as regular adults but should follow medical advice based on their health condition. Common adverse reactions during treatment may include headache, dizziness, edema, itching, dyspepsia, constipation, dry mouth, rash, erythema, sweating, arthralgia, back pain, muscle cramps, malaise, polyuria, and erectile dysfunction. If symptoms are severe or persistent, consult a physician.
nasopharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, positional dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, rash, itching, joint swelling, low back pain, arthritis, muscle cramp, lethargy, pollakiuria, polyuria, erectile dysfunction, edema, angioedema, facial swelling, peripheral edema, fatigue, flushing, weakness, facial flushing, hemoglobin decrease, hematocrit decrease, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, elevated serum potassium, vasculitis, elevated liver function levels, angioedema, myalgia, renal failure, kidney damage, elevated serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, intestinal vascular edema, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremor, hypesthesia, taste disturbance, peripheral neuropathy, hypertonicity, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urination disorder, nocturnal enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, elevated liver enzymes, chest discomfort, abdominal discomfort, gastroesophageal reflux, neck pain, hypercholesterolemia, hypoglycemia, neuroexcitability, Stevens-Johnson syndrome, chest pain, weight gain, arthralgia, skeletal pain, rhabdomyolysis, gingival overgrowth, gastritis
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. It is recommended to maintain a storage temperature of room temperature between 1 to 30 degrees Celsius.
Bright yellow oval film-coated tablets
28 tablets/box [(14 tablets/PTP)×2]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.